Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 105, Issue 4, Pages 389-395
Publisher
Wiley
Online
2014-01-23
DOI
10.1111/cas.12362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene
- (2013) R. Yamada et al. TISSUE ANTIGENS
- HSP DNAJB8 Controls Tumor-Initiating Ability in Renal Cancer Stem-like Cells
- (2012) S. Nishizawa et al. CANCER RESEARCH
- Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity
- (2012) N. Ning et al. CANCER RESEARCH
- Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients
- (2012) Hidekazu Kameshima et al. CANCER SCIENCE
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Cytotoxic T lymphocytes: Sniping cancer stem cells
- (2012) Yoshihiko Hirohashi et al. OncoImmunology
- Cytotoxic T Lymphocytes Efficiently Recognize Human Colon Cancer Stem-Like Cells
- (2011) Satoko Inoda et al. AMERICAN JOURNAL OF PATHOLOGY
- Human DNAJ in cancer and stem cells
- (2011) Jason N. Sterrenberg et al. CANCER LETTERS
- Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients
- (2011) Hidekazu Kameshima et al. CANCER SCIENCE
- Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer
- (2010) Akihiro Miyazaki et al. CANCER SCIENCE
- A DNAJB Chaperone Subfamily with HDAC-Dependent Activities Suppresses Toxic Protein Aggregation
- (2010) Jurre Hageman et al. MOLECULAR CELL
- Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer
- (2009) Ichiya Honma et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
- (2009) E. H. Huang et al. CANCER RESEARCH
- The functioning antigens: beyond just as the immunological targets
- (2009) Yoshihiko Hirohashi et al. CANCER SCIENCE
- Efficient Killing of Human Colon Cancer Stem Cells by T Lymphocytes
- (2009) M. Todaro et al. JOURNAL OF IMMUNOLOGY
- Cep55/c10orf3, a Tumor Antigen Derived From a Centrosome Residing Protein in Breast Carcinoma
- (2009) Satoko Inoda et al. JOURNAL OF IMMUNOTHERAPY
- Molecular Basis of Colorectal Cancer
- (2009) Sanford D. Markowitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Side populations of gastrointestinal cancers are not enriched in stem cells
- (2008) J Burkert et al. JOURNAL OF PATHOLOGY
- Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer
- (2008) Tetsuhiro Tsuruma et al. Journal of Translational Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now